MED MEDIFAST INC Common Stock

NYSE · Consumer products · Lihat di SEC EDGAR ↗

$12,54

Harga · Mei 20, 2026

Fundamental per Mei 4, 2026

MED Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

Harga

$12.54

Kapitalisasi Pasar

$117M

P/E (TTM)

-6.3

EPS (TTM)

$-1.70

Pendapatan (TTM)

$386M

Imbal Hasil Dividen

0.17%

ROE

-9.0%

D/E Utang/Ekuitas

—

Rentang 52M

$9 – $15

MED Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Pendapatan & Laba Bersih $386M

2016-12-31 → 2025-12-31

EPS $-1.70

2016-12-31 → 2025-12-31

Arus Kas Bebas $1M

2016-12-31 → 2025-12-31

Margin -4.8%

2016-12-31 → 2025-12-31

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik

Tren 5 Tahun

MED

Median Rekan

P/E (TTM)

-6.3

15.0

P/S (TTM)

0.3

1.8

P/B

0.6

3.3

Price / FCF (Harga / FCF)

94.0

—

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik

Tren 5 Tahun

MED

Median Rekan

Gross Margin (Margin Kotor)

71.3%

66.0%

Operating Margin (Margin Operasi)

-3.7%

—

Net Profit Margin (Margin Laba Bersih)

-4.8%

8.4%

ROA

-7.0%

11.0%

ROE

-9.0%

16.4%

ROIC

-23.7%

—

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik

Tren 5 Tahun

MED

Median Rekan

Current Ratio (Rasio Lancar)

4.7

2.9

Quick Ratio (Rasio Cepat)

3.9

—

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik

Tren 5 Tahun

MED

Median Rekan

Revenue YoY (Pendapatan YoY)

-36.0%

—

Revenue CAGR 3Y (CAGR Pendapatan 3T)

-37.7%

—

Revenue CAGR 5Y (CAGR Pendapatan 5T)

-16.2%

—

EPS YoY

-97.9%

—

Net Income YoY (Laba Bersih YoY)

-97.9%

—

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik

Tren 5 Tahun

MED

Median Rekan

EPS (Diluted)

$-1.70

—

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik

Tren 5 Tahun

MED

Median Rekan

Payout Ratio (Rasio Pembayaran Dividen)

-1.0%

—

Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun

Imbal Hasil Dividen

0.17%

Rasio Pembayaran Dividen

-1.0%

CAGR Dividen 5T

—

Tanggal ex-dividen	Jumlah
18 Sep. 2023	$1,6500
26 Juni 2023	$1,6500
27 Maret 2023	$1,6500
19 Des. 2022	$1,6400
19 Sep. 2022	$1,6400
27 Juni 2022	$1,6400
28 Maret 2022	$1,6400
20 Des. 2021	$1,4200
20 Sep. 2021	$1,4200
21 Juni 2021	$1,4200
29 Maret 2021	$1,4200
21 Des. 2020	$1,1300
21 Sep. 2020	$1,1300
29 Juni 2020	$1,1300
30 Maret 2020	$1,1300
26 Des. 2019	$1,1300
26 Sep. 2019	$0,7500
27 Juni 2019	$0,7500
28 Maret 2019	$0,7500
20 Des. 2018	$0,7500

MED Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

JUAL 9 analis

Beli Kuat 0 0,0%
Beli 0 0,0%
Tahan 4 44,4%
Jual 4 44,4%
Jual Kuat 1 11,1%

Target Harga 12 Bulan

1 analis · 2026-05-17

Rendah $12.00

Tinggi $12.00

Target median $12.00 -4,3%

Target rata-rata $12.00 -4,3%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Kejutan Rata-rata

0.06%

Periode	EPS Aktual	EPS Estimasi	Kejutan
31 Maret 2026	$-0.19	$-0.53	0.34%
31 Des. 2025	$-1.65	$-0.83	-0.82%
30 Sep. 2025	$-0.21	$-0.39	0.18%
30 Juni 2025	$0.22	$-0.22	0.44%
31 Maret 2025	$-0.11	$-0.27	0.16%

Perbandingan Sejawat Metrik utama vs rekan sektor

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
MED	$117M	-6.3	-36.0%	-4.8%	-9.0%	71.3%
NATR	$378M	20.4	5.7%	4.1%	12.0%	72.4%
HNST	$291M	-18.4	-1.9%	-4.2%	-8.8%	33.3%
USNA	$355M	33.5	8.3%	1.2%	2.0%	78.3%
NAGE	$507M	31.8	29.9%	13.4%	24.7%	64.3%
NUS	—	3.0	-14.3%	10.8%	22.0%	69.5%
FTLF	—	25.8	26.4%	—	—	—
UPXI	$114M	-1.7	-39.2%	-86.6%	-29.2%	68.7%
SKIN	$177M	-8.7	-10.0%	-3.2%	-14.1%	65.3%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Laba Rugi 15

Data Laporan Laba Rugi Tahunan untuk MED
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$386M	$602M	$1.07B	$1.60B	$1.53B	$935M	$714M	$501M	$302M	$275M	$273M	$285M
Cost of Revenue	$111M	$158M	$296M	$458M	$398M	$237M	$177M	$121M	$74M	$69M	$71M	$76M
Gross Profit	$275M	$445M	$776M	$1.14B	$1.13B	$698M	$537M	$380M	$228M	$206M	$201M	$209M
R&D Expense	$4M	$5M	$5M	$4M	$4M	$3M	$3M	$2M	$2M	$2M	$2M	$1M
SG&A Expense	$289M	$442M	$649M	$956M	$911M	$564M	$446M	$311M	$188M	$179M	$173M	$179M
Operating Income	$-14M	$3M	$126M	$185M	$216M	$134M	$91M	$69M	$40M	$27M	$29M	$30M
Other Non-op	$3M	$-4M	$-95.0K	$-747.0K	$119.0K	$-140.0K	$29.0K	$179.0K	$136.0K	$-20.0K	$326.0K	$731.0K
Pretax Income	$-6M	$4M	$129M	$184M	$216M	$134M	$92M	$71M	$40M	$27M	$30M	$32M
Income Tax	$13M	$2M	$29M	$40M	$52M	$31M	$14M	$15M	$13M	$9M	$10M	$11M
Net Income	$-19M	$2M	$99M	$144M	$164M	$103M	$78M	$56M	$28M	$18M	$20M	$13M
EPS (Basic)	$-1.70	$0.19	$9.13	$12.82	$14.01	$8.74	$6.62	$4.67	$2.32	$1.51	$1.68	$1.04
EPS (Diluted)	$-1.70	$0.19	$9.10	$12.73	$13.89	$8.68	$6.43	$4.62	$2.29	$1.49	$1.66	$1.03
Shares (Basic)	10,981,000	10,930,000	10,884,000	11,195,000	11,705,000	11,771,000	11,771,000	11,947,000	11,924,000	11,842,000	11,959,000	12,670,000
Shares (Diluted)	10,981,000	10,963,000	10,921,000	11,276,000	11,813,000	11,850,000	12,117,000	12,079,000	12,088,000	11,947,000	12,071,000	12,778,000
EBITDA	$29.0K	$16M	$140M	$196M	$223M	$141M	$96M	$73M	$44M	$32M	$36M	·

Neraca 24

Data Neraca Tahunan untuk MED
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$89M	$91M	$94M	$88M	$104M	$164M	$77M	$81M	$75M	$52M	$42M	$24M
Short-term Investments	$78M	$71M	$56M	$0	$5M	$11M	$16M	$20M	$24M	$24M	$25M	$28M
Receivables	·	·	·	·	·	$584.0K	$1M	$1M	$576.0K	$1M	$2M	$2M
Inventory	$20M	$42M	$55M	$119M	$180M	$53M	$49M	$39M	$19M	$18M	$13M	$16M
Prepaid Expense	$9M	$10M	$11M	$16M	$16M	$6M	$6M	$5M	$4M	$4M	$3M	$3M
Current Assets	$202M	$214M	$224M	$223M	$307M	$234M	$154M	$146M	$125M	$101M	$87M	$82M
PP&E (Net)	$31M	$38M	$51M	$57M	$56M	$28M	$26M	$20M	$19M	$20M	$29M	$33M
PP&E (Gross)	$99M	$96M	$99M	$97M	$89M	$55M	$49M	$54M	$52M	$56M	$75M	$74M
Accum. Depreciation	$68M	$58M	$47M	$40M	$33M	$27M	$23M	$35M	$33M	$36M	$46M	$40M
Other Non-current Assets	$8M	$10M	$15M	$12M	$6M	$3M	$353.0K	$1M	$2M	$162.0K	$205.0K	$497.0K
Total Assets	$248M	$284M	$310M	$316M	$398M	$276M	$195M	$169M	$146M	$121M	$116M	$116M
Accounts Payable	$38M	$56M	$86M	$135M	$163M	$108M	$76M	$60M	$37M	$24M	$23M	$22M
Current Liabilities	$43M	$64M	$92M	$141M	$170M	$111M	$79M	$60M	$37M	$24M	$24M	$27M
Capital Leases	$6M	$10M	$16M	$20M	$26M	$7M	$10M	·	·	·	$0	$242.0K
Deferred Tax	·	·	·	·	·	·	·	·	$208.0K	$779.0K	$4M	$5M
Total Liabilities	$49M	$74M	$108M	$161M	$196M	$119M	$90M	$60M	$37M	$25M	$28M	$35M
Common Stock	$11.0K	$11.0K	$11.0K	$11.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K
Paid-in Capital	$40M	$33M	$27M	$22M	$12M	$8M	·	$9M	$5M	$3M	$0	$1M
Retained Earnings	$158M	$177M	$175M	$140M	$190M	$154M	$169M	$131M	$104M	$93M	$89M	$79M
Treasury Stock	·	·	$0	$6M	$0	$5M	$64M	$31M	·	·	·	$0
AOCI	$234.0K	$180.0K	$248.0K	$24.0K	$111.0K	$41.0K	$25.0K	$-173.0K	$-160.0K	$-165.0K	$-62.0K	$435.0K
Stockholders' Equity	$199M	$210M	$201M	$155M	$202M	$157M	$105M	$109M	$107M	$96M	$89M	$80M
Liabilities + Equity	$248M	$284M	$310M	$316M	$398M	$276M	$195M	$169M	$146M	$121M	$116M	$116M
Shares Outstanding	10,991,000	10,938,000	10,896,000	10,873,000	11,593,000	11,772,000	11,764,000	11,868,000	11,971,000	11,871,000	11,797,000	12,075,764

Arus Kas 16

Data Arus Kas Tahunan untuk MED
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$14M	$13M	$13M	$11M	$7M	$4M	$5M	$4M	$4M	$5M	$7M	$8M
Stock-based Comp	$8M	$7M	$8M	$11M	$10M	$7M	$5M	$3M	$4M	$3M	$3M	$4M
Deferred Tax	$11M	$-7M	$1M	$-924.0K	$-4M	$601.0K	$2M	$-3M	$-623.0K	$-3M	$-106.0K	$286.0K
Restructuring	·	·	·	·	·	·	·	·	·	$1M	·	·
Other Non-cash	$-8M	$10M	$26M	$30M	$-82M	$28M	$-4M	$155.0K	$8M	$2M	$-737.0K	·
Operating Cash Flow	$7M	$24M	$148M	$195M	$95M	$145M	$84M	$61M	$43M	$25M	$29M	$26M
CapEx	$6M	$7M	$6M	$17M	$34M	$6M	$10M	$5M	$3M	$3M	$3M	$7M
Investing Cash Flow	$-8M	$-27M	$-61M	$-11M	$-29M	$-1M	$-6M	$-1M	$-3M	$-2M	$-189.0K	$-3M
Net Debt Issued	·	·	·	·	·	·	·	·	·	$-219.0K	$-255.0K	·
Stock Repurchased	$0	$0	$4M	$126M	$56M	$5M	$33M	$30M	·	·	$11M	$34M
Net Stock Activity	$0	$0	$-4M	$-126M	$-56M	$-5M	$-33M	$-30M	·	·	$-11M	·
Dividends Paid	$195.0K	$715.0K	$73M	$72M	$64M	$53M	$35M	$23M	$15M	$12M	·	·
Financing Cash Flow	$-564.0K	$-2M	$-80M	$-200M	$-125M	$-57M	$-82M	$-53M	$-17M	$-13M	$-12M	$-35M
Net Change in Cash	$-2M	$-4M	$7M	$-16M	$-60M	$87M	$-4M	$6M	$23M	$10M	$18M	$-12M
Taxes Paid	$10M	$-2M	$34M	$37M	·	·	·	·	·	·	·	·
Free Cash Flow	$1M	$17M	$141M	$178M	$60M	$139M	$74M	$56M	$40M	$22M	$27M	·

Profitabilitas 8

Data Profitabilitas Tahunan untuk MED
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	71.3%	73.8%	72.4%	71.3%	73.9%	74.7%	75.2%	75.8%	75.5%	74.9%	73.8%	·
Operating Margin	-3.7%	0.48%	11.8%	11.6%	14.2%	14.3%	12.8%	13.8%	13.1%	9.8%	10.5%	·
Net Margin	-4.8%	0.35%	9.3%	9.0%	10.8%	11.0%	10.9%	11.1%	9.2%	6.5%	7.3%	·
Pretax Margin	-1.5%	0.63%	12.0%	11.5%	14.2%	14.4%	12.9%	14.1%	13.4%	9.9%	10.9%	·
EBITDA Margin	0.01%	2.6%	13.0%	12.2%	14.6%	15.1%	13.4%	14.7%	14.5%	11.8%	13.1%	·
ROA	-7.0%	0.70%	31.8%	40.2%	48.6%	43.7%	42.8%	35.4%	20.8%	15.0%	17.2%	·
ROE	-9.0%	1.0%	50.4%	94.0%	82.3%	69.2%	72.1%	50.5%	27.1%	19.3%	23.7%	·
ROIC	-23.7%	0.76%	48.4%	93.0%	81.1%	65.4%	73.3%	50.1%	25.1%	18.4%	21.3%	·

Likuiditas & Solvabilitas 2

Data Likuiditas & Solvabilitas Tahunan untuk MED
Metrik	Tren	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio		4.7	3.3	2.4	1.6	1.8	2.1	1.9	2.4	3.4	4.1	3.7	·
Quick Ratio		3.9	2.5	1.0	0.6	0.6	1.6	1.2	1.7	2.7	3.2	2.9	·

Efisiensi 3

Data Efisiensi Tahunan untuk MED
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	1.4	2.0	3.4	4.5	4.5	4.0	3.9	3.2	2.3	2.3	2.3	·
Inventory Turnover	3.5	3.3	3.4	3.1	3.4	4.6	4.0	4.1	3.9	4.4	4.9	·
Receivables Turnover	·	·	·	·	·	925.1	583.1	467.4	307.2	181.8	166.2	·

Per Saham 6

Data Per Saham Tahunan untuk MED
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$18.10	$19.21	$18.49	$14.26	$17.47	$13.36	$8.91	$9.19	$9.07	$8.09	$7.51	·
Revenue / Share	$35.13	$54.95	$98.16	$141.77	$129.19	$78.89	$58.90	$41.48	$24.95	$22.98	$22.60	·
Cash Flow / Share	$0.62	$2.23	$13.52	$17.26	$8.00	$12.25	$6.95	$5.03	$3.58	$2.12	$2.44	·
Cash / Share	$8.13	$8.31	$8.67	$8.06	$8.99	$13.91	$6.54	$6.86	$6.27	$4.42	$3.56	·
Dividend / Share	$0	$0	$5	$7	$6	$5	$3	$2	$1	$1	$0	$0
EPS (TTM)	$-1.70	$0.19	$9.10	$12.73	$13.89	$8.68	$6.43	$4.62	$2.29	$1.49	$1.66	$1.03

Tingkat Pertumbuhan 8

Data Tingkat Pertumbuhan Tahunan untuk MED
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	-36.0%	-43.8%	-32.9%	4.8%	63.2%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-37.7%	-26.6%	4.7%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-16.2%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	·	-97.9%	-28.5%	-8.3%	60.0%	·	·	·	·	·	·	·
EPS CAGR 3Y	·	-76.1%	1.6%	·	·	·	·	·	·	·	·	·
Net Income YoY	·	-97.9%	-30.8%	-12.5%	59.5%	·	·	·	·	·	·	·
Net Income CAGR 3Y	·	-76.6%	-1.1%	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	-67.4%	·	·	·	·	·	·	·	·	·	·	·

Valuasi (TTM) 13

Data Valuasi (TTM) Tahunan untuk MED
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$386M	$602M	$1.07B	$1.60B	$1.53B	$935M	$714M	$501M	$302M	$275M	$273M	$285M
Net Income TTM	$-19M	$2M	$99M	$144M	$164M	$103M	$78M	$56M	$28M	$18M	$20M	$13M
Market Cap	$117M	$193M	$732M	$1.25B	$2.43B	$2.31B	$1.29B	$1.48B	$836M	$494M	$358M	·
P/E	-6.3	92.7	7.4	9.1	15.1	22.6	17.0	27.1	30.5	27.9	18.3	32.6
P/S	0.3	0.3	0.7	0.8	1.6	2.5	1.8	3.0	2.8	1.8	1.3	·
P/B	0.6	0.9	3.6	8.1	12.0	14.7	12.3	13.6	7.7	5.1	4.0	·
P / Tangible Book	0.6	0.9	3.6	8.1	12.0	14.7	·	·	·	·	·	·
P / Cash Flow	17.1	7.9	5.0	6.4	25.7	15.9	15.3	24.4	19.3	19.5	12.2	·
P / FCF	94.0	11.3	5.2	7.1	40.2	16.6	17.4	26.6	20.9	22.0	13.5	·
Dividend Yield	0.17%	0.37%	10.0%	5.7%	2.6%	2.3%	2.8%	1.6%	1.8%	2.4%	·	·
Earnings Yield	-15.9%	1.1%	13.5%	11.0%	6.6%	4.4%	5.9%	3.7%	3.3%	3.6%	5.5%	3.1%
Payout Ratio	-1.0%	34.2%	73.5%	49.9%	38.9%	51.7%	45.4%	41.5%	55.5%	66.7%	·	·
Annual Payout	$195.0K	$715.0K	$73M	$72M	$64M	$53M	$35M	$23M	$15M	$12M	·	·

Laporan Laba Rugi 15

Data Triwulanan Laporan Laba Rugi untuk MED
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$76M	$75M	$89M	$106M	$116M	$119M	$140M	$169M	$175M	$191M	$236M	$296M	$349M	$337M	$390M	$453M
Cost of Revenue	$24M	$23M	$27M	$29M	$31M	$31M	$34M	$45M	$47M	$50M	$58M	$85M	$103M	$104M	$108M	$132M
Gross Profit	$52M	$52M	$62M	$77M	$84M	$88M	$106M	$123M	$127M	$141M	$177M	$211M	$246M	$234M	$283M	$322M
SG&A Expense	$55M	$60M	$66M	$78M	$86M	$88M	$104M	$131M	$119M	$133M	$152M	$172M	$193M	$201M	$235M	$273M
Operating Income	$-3M	$-8M	$-4M	$-1M	$-1M	$708.0K	$2M	$-8M	$8M	$9M	$26M	$39M	$54M	$33M	$48M	$49M
Interest Income	$1M	·	$1M	$1M	$1M	·	$1M	$1M	$1M	·	·	·	·	·	·	·
Other Non-op	$-25.0K	$-1M	$-2.0K	$3M	$487.0K	$-2M	$-2M	$-4M	$4M	$-50.0K	$7.0K	$-51.0K	$-1.0K	$-710.0K	$-17.0K	$-4.0K
Pretax Income	$-2M	$-6M	$-3M	$3M	$526.0K	$1M	$2M	$-11M	$12M	$10M	$27M	$39M	$53M	$32M	$48M	$49M
Income Tax	$181.0K	$12M	$-396.0K	$395.0K	$1M	$474.0K	$449.0K	$-2M	$3M	$4M	$3M	$9M	$13M	$6M	$12M	$10M
Net Income	$-2M	$-18M	$-2M	$2M	$-772.0K	$800.0K	$1M	$-8M	$8M	$6M	$23M	$30M	$40M	$27M	$36M	$39M
EPS (Basic)	$-0.19	$-1.65	$-0.21	$0.23	$-0.07	$0.08	$0.10	$-0.75	$0.76	$0.55	$2.12	$2.78	$3.68	$2.46	$3.30	$3.44
EPS (Diluted)	$-0.19	$-1.64	$-0.21	$0.22	$-0.07	$0.08	$0.10	$-0.75	$0.76	$0.54	$2.12	$2.77	$3.67	$2.45	$3.27	$3.42
Shares (Basic)	11,006,000	-21,949,000	10,991,000	10,991,000	10,948,000	-21,853,000	10,937,000	10,937,000	10,909,000	-21,760,000	10,892,000	10,888,000	10,864,000	-22,680,000	10,964,000	11,354,000
Shares (Diluted)	11,006,000	-22,018,000	10,991,000	11,060,000	10,948,000	-21,903,000	10,971,000	10,937,000	10,958,000	-21,828,000	10,933,000	10,917,000	10,899,000	-22,839,000	11,042,000	11,435,000
EBITDA	$188.0K	·	$-4M	$-1M	$2M	·	$2M	$-8M	$11M	·	$26M	$39M	$56M	·	$48M	$49M

Neraca 22

Data Triwulanan Neraca untuk MED
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$72M	$89M	$100M	$102M	$92M	$91M	$115M	$108M	$97M	·	$113M	$147M	$124M	·	$70M	$61M
Short-term Investments	$97M	$78M	$74M	$61M	$73M	$71M	$55M	$55M	$59M	·	·	·	·	·	$0	$0
Inventory	$21M	$20M	$23M	$30M	$39M	$42M	$40M	$40M	$46M	·	$58M	$69M	$97M	·	$145M	$157M
Prepaid Expense	$7M	$9M	$7M	$9M	$10M	$10M	$7M	$12M	$11M	·	$8M	$13M	$10M	·	$14M	$17M
Current Assets	$203M	$202M	$208M	$206M	$214M	$214M	$225M	$224M	$220M	·	$224M	$229M	$230M	·	$230M	$243M
PP&E (Net)	$30M	$31M	$33M	$35M	$36M	$38M	$39M	$40M	$51M	·	$53M	$54M	$56M	·	$58M	$59M
PP&E (Gross)	·	$99M	·	·	·	$96M	·	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	$68M	·	·	·	$58M	·	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$7M	$8M	$7M	$8M	$9M	$10M	$11M	$12M	$14M	·	$16M	$14M	$14M	·	$13M	$13M
Total Assets	$252M	$248M	$268M	$269M	$280M	$284M	$291M	$294M	$303M	·	$320M	$319M	$322M	·	$326M	$341M
Accounts Payable	$38M	$38M	$41M	$40M	$52M	$56M	$66M	$69M	$71M	·	$103M	$105M	$113M	·	$148M	$155M
Current Liabilities	$42M	$43M	$47M	$46M	$61M	$64M	$72M	$75M	$77M	·	$110M	$115M	$132M	·	$154M	$188M
Capital Leases	$12M	$6M	$7M	$7M	$8M	$10M	$12M	$13M	$15M	·	$17M	$18M	$19M	·	$22M	$23M
Total Liabilities	$54M	$49M	$54M	$53M	$69M	$74M	$84M	$88M	$92M	·	$127M	$133M	$151M	·	$176M	$211M
Common Stock	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	·	$11.0K	$11.0K	$11.0K	·	$11.0K	$11.0K
Paid-in Capital	$41M	$40M	$38M	$37M	$35M	$33M	$31M	$30M	$28M	·	$24M	$22M	$19M	·	$19M	$0
Retained Earnings	$156M	$158M	$176M	$178M	$176M	$177M	$176M	$175M	$183M	·	$169M	$164M	$152M	·	$132M	$129M
Treasury Stock	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	·	·	·
AOCI	$33.0K	$234.0K	$220.0K	$179.0K	$239.0K	$180.0K	$349.0K	$26.0K	$22.0K	·	$141.0K	$123.0K	$33.0K	·	$391.0K	$268.0K
Stockholders' Equity	$198M	$199M	$215M	$216M	$211M	$210M	$207M	$205M	$211M	$201M	$193M	$186M	$171M	$155M	$151M	$129M
Liabilities + Equity	$252M	$248M	$268M	$269M	$280M	$284M	$291M	$294M	$303M	·	$320M	$319M	$322M	·	$326M	$341M
Shares Outstanding	11,119,000	10,991,000	10,991,000	10,991,000	10,991,000	10,938,000	10,937,000	10,937,000	10,937,000	·	10,892,000	10,889,000	10,887,000	·	10,928,000	11,018,000

Arus Kas 14

Data Triwulanan Arus Kas untuk MED
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$3M	$3M	$3M	$4M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M
Stock-based Comp	$2M	$2M	$910.0K	$3M	$2M	$2M	$606.0K	$2M	$2M	$2M	$3M	$3M	$606.0K	$3M	$3M	$3M
Deferred Tax	$0	$12M	$-648.0K	$-20.0K	$20.0K	$-8M	$106.0K	$-103.0K	$112.0K	$7M	$-6M	$0	$800.0K	$822.0K	$-2M	$0
Other Non-cash	$-3M	·	·	·	$-1M	·	·	·	$-7M	·	·	·	$20M	·	·	·
Operating Cash Flow	$260.0K	$-5M	$12M	$-3M	$3M	$-5M	$9M	$13M	$7M	$11M	$30M	$43M	$64M	$52M	$55M	$44M
CapEx	$1M	$1M	$1M	$1M	$2M	$2M	$1M	$2M	$2M	$946.0K	$2M	$2M	$2M	$9M	$2M	$3M
Investing Cash Flow	$-17M	$-5M	$-14M	$13M	$-2M	$-19M	$-2M	$-3M	$-3M	$-11M	$-46M	$-2M	$-2M	$-9M	$-2M	$1M
Stock Repurchased	·	·	·	·	·	$0	$0	$0	$0	$0	$0	$0	$4M	$6M	$20M	$110M
Net Stock Activity	·	·	·	·	·	·	·	·	$0	·	·	·	$-4M	·	·	·
Dividends Paid	$87.0K	$0	$0	$1.0K	$194.0K	$0	$1.0K	$4.0K	$710.0K	$18M	$18M	$18M	$19M	$18M	$18M	$19M
Financing Cash Flow	$-901.0K	$1.0K	$0	$-2.0K	$-563.0K	$-1.0K	$-3.0K	$-20.0K	$-1M	$-18M	$-18M	$-18M	$-26M	$-24M	$-45M	$-102M
Net Change in Cash	$-18M	$-10M	$-2M	$10M	$789.0K	$-24M	$7M	$11M	$3M	$-18M	$-35M	$24M	$36M	$18M	$9M	$-57M
Taxes Paid	$241.0K	·	·	·	$3M	·	·	·	$-100.0K	·	·	·	$-46.0K	$3M	$4M	$30M
Free Cash Flow	$-836.0K	·	·	·	$2M	·	·	·	$5M	·	·	·	$62M	·	·	·

Profitabilitas 8

Data Triwulanan Profitabilitas untuk MED
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Gross Margin	68.1%	·	69.5%	72.6%	72.8%	·	75.4%	73.2%	72.9%	·	75.2%	71.1%	70.6%	·	72.5%	71.0%
Operating Margin	-4.3%	·	-4.6%	-1.0%	-1.1%	·	1.5%	-4.7%	4.5%	·	10.8%	13.1%	15.3%	·	12.3%	10.8%
Net Margin	-2.8%	·	-2.5%	2.4%	-0.67%	·	0.81%	-4.8%	4.8%	·	9.8%	10.2%	11.5%	·	9.3%	8.6%
Pretax Margin	-2.5%	·	-3.0%	2.7%	0.45%	·	1.1%	-6.3%	6.6%	·	11.3%	13.2%	15.3%	·	12.3%	10.8%
EBITDA Margin	0.25%	·	-4.6%	-1.0%	1.7%	·	1.5%	-4.7%	6.4%	·	10.8%	13.1%	16.2%	·	12.3%	10.8%
ROA	-0.80%	·	-0.81%	0.88%	-0.26%	·	0.37%	-2.7%	2.7%	·	7.2%	9.2%	10.8%	·	10.4%	11.1%
ROE	-1.0%	·	-1.1%	1.2%	-0.37%	·	0.56%	-4.2%	4.4%	·	13.5%	19.2%	20.7%	·	20.8%	24.1%
ROIC	-1.8%	·	-1.6%	-0.43%	0.88%	·	0.73%	-2.9%	2.7%	·	11.5%	16.2%	23.5%	·	24.2%	30.3%

Likuiditas & Solvabilitas 2

Data Triwulanan Likuiditas & Solvabilitas untuk MED
Metrik	Tren	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio		4.8	·	4.4	4.5	3.5	·	3.1	3.0	2.8	·	2.0	2.0	1.7	·	1.5	1.3
Quick Ratio		4.0	·	3.7	3.5	2.7	·	2.3	2.2	2.0	·	1.0	1.3	0.9	·	0.5	0.3

Efisiensi 2

Data Triwulanan Efisiensi untuk MED
Metrik	Tren	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover		0.3	·	0.3	0.4	0.4	·	0.5	0.6	0.6	·	0.7	0.9	0.9	·	1.1	1.3
Inventory Turnover		0.8	·	0.9	0.8	0.7	·	0.7	0.8	0.7	·	0.6	0.8	0.7	·	0.8	1.0

Per Saham 6

Data Triwulanan Per Saham untuk MED
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$17.78	·	$19.53	$19.65	$19.19	·	$18.96	$18.77	$19.29	·	$17.72	$17.04	$15.70	·	$13.77	$11.75
Revenue / Share	$6.91	·	$8.13	$9.54	$10.57	·	$12.78	$15.41	$15.95	·	$21.57	$27.13	$32.02	·	$35.36	$39.64
Cash Flow / Share	$0.02	·	·	·	$0.31	·	·	·	$0.66	·	·	·	$5.88	·	·	·
Cash / Share	$6.43	·	$9.06	$9.25	$8.34	·	$10.54	$9.88	$8.91	·	$10.35	$13.54	$11.37	·	$6.38	$5.54
Dividend / Share	·	·	·	·	·	$0	$0	$0	$0	$0	$2	$2	$2	$2	$2	$2
EPS (TTM)	$-0.25	·	$0.04	$-0.50	$0.04	·	$2.23	$4.90	$9.32	·	$11.83	$13.13	$13.95	·	$13.84	$14.53

Valuasi (TTM) 11

Data Triwulanan Valuasi (TTM) untuk MED
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$387M	·	$451M	$530M	$599M	·	$719M	$875M	$1.06B	·	$1.27B	$1.49B	$1.61B	·	$1.67B	$1.68B
Net Income TTM	$-3M	·	$576.0K	$-5M	$519.0K	·	$24M	$54M	$102M	·	$130M	$146M	$157M	·	$159M	$170M
Market Cap	$113M	·	$150M	$154M	$148M	·	$209M	$239M	$419M	·	$815M	$1.00B	$1.13B	·	$1.18B	$1.99B
P/E	-40.8	·	341.8	-28.1	337.0	·	8.6	4.5	4.1	·	6.3	7.0	7.4	·	7.8	12.4
P/S	0.3	·	0.3	0.3	0.2	·	0.3	0.3	0.4	·	0.6	0.7	0.7	·	0.7	1.2
P/B	0.6	·	0.7	0.7	0.7	·	1.0	1.2	2.0	·	4.2	5.4	6.6	·	7.9	15.4
P / Tangible Book	0.6	·	0.7	0.7	0.7	·	1.0	1.2	2.0	·	4.2	5.4	6.6	·	7.9	15.4
P / Cash Flow	435.8	·	·	·	43.5	·	·	·	57.6	·	·	·	17.6	·	·	·
P / FCF	-135.5	·	·	·	78.6	·	·	·	77.0	·	·	·	18.2	·	·	·
Earnings Yield	-2.5%	·	0.29%	-3.6%	0.30%	·	11.7%	22.5%	24.3%	·	15.8%	14.2%	13.5%	·	12.8%	8.1%
Payout Ratio	-4.1%	·	·	·	-25.1%	·	·	·	8.5%	·	·	·	47.9%	·	·	·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Laporan Laba Rugi

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$386M	$602M	$1.07B	$1.60B	$1.53B
Margin Kotor %	71.3%	73.8%	72.4%	71.3%	73.9%
Margin Operasi %	-3.7%	0.48%	11.8%	11.6%	14.2%
Laba Bersih	$-19M	$2M	$99M	$144M	$164M
EPS Dilusian	$-1.70	$0.19	$9.10	$12.73	$13.89

Neraca

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rasio Lancar	4.7	3.3	2.4	1.6	1.8
Rasio Cepat	3.9	2.5	1.0	0.6	0.6

Arus Kas

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$1M	$17M	$141M	$178M	$60M

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

📊

Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

MED Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

MED Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Rata-rata bergerak dan lapisan tumpang tindih

Volume

Osilator

Momentum dan tren

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun

MED Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

Target Harga 12 Bulan

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Perbandingan Sejawat Metrik utama vs rekan sektor

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap